Sánchez J, Holmgren J
Facultad de Medicina, UAEM, Av. Universidad 1001, Col. Chamilpa, Mexico.
Cell Mol Life Sci. 2008 May;65(9):1347-60. doi: 10.1007/s00018-008-7496-5.
Many notions regarding the function, structure and regulation of cholera toxin expression have remained essentially unaltered in the last 15 years. At the same time, recent findings have generated additional perspectives. For example, the cholera toxin genes are now known to be carried by a non-lytic bacteriophage, a previously unsuspected condition. Understanding of how the expression of cholera toxin genes is controlled by the bacterium at the molecular level has advanced significantly and relationships with cell-density-associated (quorum-sensing) responses have recently been discovered. Regarding the cell intoxication process, the mode of entry and intracellular transport of cholera toxin are becoming clearer. In the immunological field, the strong oral immunogenicity of the non-toxic B subunit of cholera toxin (CTB) has been exploited in the development of a now widely licensed oral cholera vaccine. Additionally, CTB has been shown to induce tolerance against co-administered (linked) foreign antigens in some autoimmune and allergic diseases.
在过去15年里,许多关于霍乱毒素表达的功能、结构和调控的观念基本没有改变。与此同时,最近的研究结果带来了新的观点。例如,现在已知霍乱毒素基因由一种非裂解性噬菌体携带,这是之前未曾料到的情况。在分子水平上,对霍乱毒素基因表达如何受细菌控制的理解有了显著进展,并且最近发现了它与细胞密度相关(群体感应)反应的关系。关于细胞中毒过程,霍乱毒素的进入方式和细胞内转运变得更加清晰。在免疫学领域,霍乱毒素无毒B亚基(CTB)强大的口服免疫原性已被用于开发目前广泛获批的口服霍乱疫苗。此外,在一些自身免疫性和过敏性疾病中,CTB已被证明能诱导对共同给药(连接)的外来抗原产生耐受性。